相关实验视频

Updated: Jun 14, 2025

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Published on: April 15, 2014

81.9K

抗NMDAR脑炎和MOGAD - 临床和治疗见解

Areeb Fatima1, Maryam Adnan2, Muhammad Irtaza Hussain Bakhtiari1

  • 1Department of Medicine, Gujranwala Medical College, Gondlanwala Village, Alipur Chatha Road, Gujranwala 52250, Pakistan.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
|May 20, 2025
PubMed
概括

这项针对抗NMDAR脑炎和MOGAD的研究发现了高复发率和Rituximab疗效. 它建议对抗体相互作用进行全面评估和进一步研究,以更好地管理这种复杂的疾病.

关键词:
抗NMDAR脑炎的治疗方法认知缺陷 认知缺陷莫加德 - 莫加德磁力共振成像 (MRI) 的病变生活质量生活的质量.复发率是指复发率是指复发率.里图西马布 (Rituximab) 是一种药物.

更多相关视频

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

16.3K
A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood07:20

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

Published on: January 9, 2018

9.8K

相关概念视频

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170